SPECIAL BULLETIN COVID-19 #25: Emergency Update to NC Medicaid and NC Health Choice Preferred Drug List (PDL) and REMS Program Flexibilities
Friday, March 27, 2020
Preferred Drug List (PDL) Update
Effective March 25, 2020, due to drug shortages in the marketplace, the NC Medicaid and NC Health Choice PDL Category of “Respiratory: Beta-Adrenergic Handheld, Short Acting” has changed to the following:
Preferred | Non-Preferred |
albuterol HFA inhaler (generic for Proair® HFA Inhaler / Proventil® HFA Inhaler / Ventolin® HFA Inhaler) | levalbuterol HFA inhaler (generic for Xopenex® HFA Inhaler) |
Proair® HFA Inhaler | Proair® DigihalerTM Inhaler |
Proair® RespiClick® Inhaler | |
Proventil® HFA Inhaler | |
Ventolin® HFA Inhaler | |
Xopenex® HFA Inhaler |
Please visit the following site for a full PDL listing: https://medicaid.ncdhhs.gov/documents/preferred-drug-list
Updated Guidance for REMS Requirements
NC Medicaid would like to share information about recent FDA guidance regarding REMS requirements during the COVID-19 public health emergency.
Please visit https://www.fda.gov/media/136317/download for the current recommendations.
Share this page: